Skip to content

📅 Economic Calendar
💬 Forum

00:00:00
ISTANBUL

About
Contact
Algo & Scripts
Market news
Privacy Policy
Brokers
Prop Firms
Psychology
Strategies
Tools
Trading
Survivor’s Notes

Search for:

Search for:

This biotech is leading what could be a ‘GLP-1 moment for hair loss,’ says BTIG

Leave a Comment / Uncategorized / By The Survivor

BTIG initiated research coverage with a buy rating, calling the biotech’s experimental hair loss treatment a possible ‘GLP-1 moment.’

← Previous Post

Related Posts

Wells Fargo double upgrades this oil and gas stock on improved capital efficiency and Permian productivity

Iran war means the U.S. will need to restock ammo. Two defense stocks stand to benefit

Leave a Comment Cancel Reply

Your email address will not be published. Required fields are marked *

Type here..

Name*

Email*

Website

Save my name, email, and website in this browser for the next time I comment.

Δ

About
Contact
Algo & Scripts
Market news
Privacy Policy
Brokers
Prop Firms
Psychology
Strategies
Tools
Trading
Survivor’s Notes

Financial Disclaimer

Copyright © 2026 The Market Survivor | Powered by The Market Survivor